MLP Q1 2024 Earnings Net Loss Per Share Improves as Company Advances Strategic Land Initiatives BLNK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Biogen Q1 2026 Earnings Strong EPS Surprise of 2634 Boosts Investor Confidence Dianthus Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline BioRad BIO Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Despite Headwinds ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase